Skip to main content
OpenTrials
Completed

NCT Number: NCT06085599

The Effect of Exercises on Pain and Kinesiophobia in Transplant Patients

Liver transplantation is a treatment method used in acute and chronic liver failure. Progressive Relaxation Exercises, which are non-pharmacological methods aimed at minimizing complications and improving the quality of life after liver transplantation, have been reported to have many benefits such as reducing acute and chronic pain, reducing fatigue and reducing muscle tension. Therefore, in this study, the effects of progressive relaxation exercises on pain and kinesiophobia in liver transplant patients were examined.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

İnonu Üniversitesi Turgut Özal tıp Merkezi Karaciğer Nakil Enstitüsü

Malatya, 44090, Turkey (Türkiye)

About this study

Liver transplantation is a common treatment for acute and chronic liver failure, liver malignancy and complicated cirrhosis. Although life expectancy increases after liver transplantation, some undesirable problems such as rejection, cardiovascular risk factors, hypertension, infection and malignancy occur. Preferring non-pharmacological methods to minimise complications and improve quality of life accelerates the return of the individual to normal life. Progressive Relaxation Exercises, one of these methods, can activate the parasympathetic nervous system, blood pressure, heart and respiratory rate can be kept within clinically normal limits due to vasodilatation in the blood vessels in the peripheral area and oxygen requirement is reduced. PGE has been reported to have many benefits such as reducing the effects of anxiety and stress, reducing acute and chronic pain, nausea and vomiting, facilitating sleep, reducing fatigue, reducing respiration, blood pressure, heart rate and muscle tension. Therefore, in this study, the effects of progressive relaxation exercises on pain and kinesiophobia in liver transplant patients were examined.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients over the age of 18 who agreed to participate in the study,
  • Patients undergoing Liver Transplantation
  • Patients without a disabling psychiatric disorder

Exclusion criteria

  • Patients under the age of 18 who do not agree to participate in the study.
  • Those who have a psychiatric diagnosis that prevents communication.

Treatment and study plan

progressive relaxation exercises

Behavioral

The progressive muscle relaxation technique involves suggestive stretching and relaxation in sixteen different muscle groups of the body. This technique is based on tensing each muscle group for approximately 10 seconds and then abruptly releasing this tension.

Primary outcomes

  1. Pain Level

    Time frame: up to 24 hours liver transplant (0-1 day

    The pain levels of the patients were measured by means of the visual pain scale.

    [Time Frame: up to 24 hours post-surgery (0-1 day)]

  2. Tampa Kinesiophobia Scale (TKS)

    Time frame: up to 24 hours liver transplant (0-1 day

    The kinesiophobia levels of the patients were evaluated postoperatively and 24 hours after surgery.

Sponsors and collaborators

Lead sponsor

Gurkan KAPIKIRAN

Other

Registry information

Official study title

The Effect of Progressive Relaxation Exercises on Pain and Kinesiophobia After Liver Transplantation

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Oct 17, 2023
Registry last updated
Oct 19, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.